Simultaneous analysis of acyclovir and its metabolite using hydrophilic interaction liquid chromatography–tandem mass spectrometry
Journal of Analytical Toxicology · 2024
DOI: 10.1093/jat/bkae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Saki Takeda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Acyclovir, Antiviral Agents, Hydrophobic and Hydrophilic Interactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
The antiviral drug acyclovir (ACV) may induce drug-induced neuropsychiatric symptoms as side effects. The detailed pathogenic mechanism remains unclear; however, it is hypothesized that 9-carboxymethoxymethylguanine (CMMG), a metabolite of ACV, is the causative compound. Therefore, the blood concentrations of ACV and CMMG should be analyzed in ACV toxicity studies. However, it is rare to find methods that can sufficiently separate the ACV and CMMG peaks during simultaneous analysis of both compounds. Therefore, we intended to develop a liquid chromatography–tandem mass spectrometry method with improved peak separation of analytes. Samples were deproteinized using methanol/acetonitrile solution (6:4, v/v). Analytes were separated on an InertSustain® Amide column (3 μm, 2.1 mm × 150 mm). The mobile phase consisted of acetonitrile/10 mM ammonium formate (5:95, v/v) (A) and acetonitrile/10 mM ammonium formate (95:5, v/v, pH 5.0) (B) and samples were eluted in the gradient mode. The separation of analytes was satisfactory and the peak shapes were good. Linear regression models weighted 1/x2 were obtained in the range of 0.25–10 μg/mL. The range of quality control (QC) bias was between 3.6% and 19.8%, and the within-run and between-run precisions of QC were within 13.5%. Recovery ranged from 83.6% to 103.7%, but ion suppression was observed. Samples from a patient with ACV encephalopathy were analyzed using this method. The resulting blood ACV and CMMG concentrations were 8.2 and 8.5 μg/mL, respectively. This method, with sufficient separation of ACV and CMMG, proved useful for use in ACV toxicity studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan.
- Department of Regional Emergency Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
- Department of Emergency and Critical Care Medicine, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan.
ORCID-Profile: Saki Takeda
Zitieren
APA
Takeda, S., Ueno, S., Zenda, R., Muto, K., Iseki, K., & Harada, K. (2024). Simultaneous analysis of acyclovir and its metabolite using hydrophilic interaction liquid chromatography–tandem mass spectrometry. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae019
Vancouver
Takeda S, Ueno S, Zenda R, Muto K, Iseki K, Harada K. Simultaneous analysis of acyclovir and its metabolite using hydrophilic interaction liquid chromatography–tandem mass spectrometry. Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae019
BibTeX
@article{Takeda2024,
author = {Takeda, Saki and Ueno, Satoshi and Zenda, Rie and Muto, Kazuya and Iseki, Ken and Harada, Kazuki},
title = {Simultaneous analysis of acyclovir and its metabolite using hydrophilic interaction liquid chromatography–tandem mass spectrometry},
journal = {Journal of Analytical Toxicology},
year = {2024},
doi = {10.1093/jat/bkae019}
}
EUVIMED